Article Text

Download PDFPDF
Systematic review
Intensive insulin therapy in hospitalised patients increases the risk of hypoglycaemia and has no effect on mortality, infection risk or length of stay

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests EN has received research support from the National Institutes of Health, American Diabetes Association, Glaxo SmithKline, Novo Nordisk, Boeringer Ingelheim and Bristol-Myers Squibb.